Highbury Group

Highbury Group is an early-stage venture capital firm based in Seattle, Washington, founded in 2014 by Dr. Ling Wong. The firm is dedicated to partnering with entrepreneurs to develop transformative technologies across various sectors, including life sciences, healthcare, software, consumer products, and emerging platforms. Dr. Wong, who has a strong background in health and technology investments, aims to leverage scientific advancements to create companies that positively impact humanity. Her experience includes establishing substantial investment portfolios at the Gates Foundation and making significant contributions to notable investments and exits in the industry. Highbury Group seeks to disrupt the status quo by supporting innovative solutions that enhance human health and societal well-being.

Ling Wong

Founder and General Partner

8 past transactions

Devoted

Series E in 2023
Devoted Health, established in 2017 and headquartered in Newton, Massachusetts, specializes in providing comprehensive healthcare solutions for Medicare beneficiaries in the United States. The company offers Medicare Advantage plans, along with personalized care through dedicated health guides, both in-person and virtually. Devoted Health aims to improve the health and well-being of older Americans by combining access to top local providers, virtual and in-home care through Devoted Medical, and advanced technology to deliver tailored healthcare experiences.

ScienceIO

Seed Round in 2021
ScienceIO is a Massachusetts-based company established in 2019 by Gaurav Kaushik and Will Manidis. It specializes in developing a biomedical language platform that transforms unstructured biomedical data into contextualized information. The platform is designed to detect and extract biomedical terms, clinical variables, and medical codes from complex medical texts, thereby linking this information to create actionable insights. By connecting medical concepts, ScienceIO enables users to perform powerful queries and gain easy access to relevant medical data and alternatives, facilitating better decision-making in the biomedical field.

Q Bio

Series B in 2020
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Edify

Seed Round in 2019
Edify is a cloud-native platform that provides an all-in-one solution for contact center operations and unified communications. Its flagship product, Edify CX, delivers a comprehensive omnichannel experience, allowing users to manage customer interactions seamlessly across various channels. The platform incorporates artificial intelligence and machine learning to facilitate automated assistance, enhancing operational efficiency. In addition to Edify CX, the company offers Edify EX for unified communications, Edify Developer for communication platform as a service (CPaaS), and Edify Workflows, which provides no-code solutions to replace traditional voice response and automation systems. Edify aims to strengthen connections between businesses and their customers, as well as improve internal communication among teams, all backed by a robust uptime guarantee.

Cradle Genomics

Series A in 2019
Cradle Genomics, Inc. is a biotechnology company focused on advancing non-invasive prenatal testing (NIPT) through comprehensive fetal genetic analysis and pregnancy health screening solutions. Founded in 2018 and headquartered in San Diego, California, with research and development operations in Detroit, Michigan, the company aims to enhance the knowledge available to expectant parents. Cradle Genomics specializes in analyzing fetal cells collected during the first trimester, allowing for rapid and safe testing that poses no risk to the mother or developing fetus. By providing critical insights early in pregnancy, Cradle Genomics empowers women to make informed health decisions.

Devoted

Series B in 2018
Devoted Health, established in 2017 and headquartered in Newton, Massachusetts, specializes in providing comprehensive healthcare solutions for Medicare beneficiaries in the United States. The company offers Medicare Advantage plans, along with personalized care through dedicated health guides, both in-person and virtually. Devoted Health aims to improve the health and well-being of older Americans by combining access to top local providers, virtual and in-home care through Devoted Medical, and advanced technology to deliver tailored healthcare experiences.

Spring Discovery

Seed Round in 2018
Spring Discovery, Inc. is a biotechnology company based in Palo Alto, California, that specializes in the development of a machine learning-based drug discovery platform. This platform is designed to expedite the identification of therapies targeting the biological processes of aging and related diseases. By focusing on the underlying mechanisms of aging, Spring Discovery aims to uncover new treatments for various age-related conditions, including cardiovascular and neurodegenerative diseases. The company's innovative approach seeks to enhance healthy lifespans and improve the quality of life for the aging population.

Q Bio

Series A in 2018
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.